Log In
BCIQ
Print this Print this
 

4Kscore test

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionTest that uses a panel of kallikrein biomarkers to detect prostate cancer
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict prostate cancer prior to biopsy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today